# Charles River Laboratories to Present at William Blair and Jefferies Conferences
Canonical URL: https://biopharmsignal.com/news/CRL/charles-river-laboratories-to-present-at-william-blair-and-jefferies-conferences
Ticker: CRL
Company: Charles River
Source: Charles River
Published: 2026-06-25 13:46 EST
Original Source URL: https://ir.criver.com
## Summary

WILMINGTON, Mass. --(BUSINESS WIRE)--Jun. 1, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 46 th Annual Growth Stock Conference on Tuesday, June 2 nd, at 10:00 a.m. CT ( 11:00 a.m.

## Article Body
WILMINGTON, Mass. --(BUSINESS WIRE)--Jun. 1, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 46 th Annual Growth Stock Conference on Tuesday, June 2 nd, at 10:00 a.m. CT ( 11:00 a.m.
## Recent Company News
- 2026-06-25 13:46 EST — [Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise](https://biopharmsignal.com/news/CRL/charles-river-joins-lilly-tunelab-to-optimize-ai-ml-platform-through-nonclinical-testing-expertise) — Source: Charles River
- 2026-06-25 13:46 EST — [Charles River Laboratories to Present at William Blair and Jefferies Conferences](https://biopharmsignal.com/news/CRL/charles-river-laboratories-to-present-at-william-blair-and-jefferies-conferences) — Source: Charles River
- 2026-06-25 13:46 EST — [Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions](https://biopharmsignal.com/news/CRL/charles-river-laboratories-and-medipost-sign-non-exclusive-mou-to-advance-gmp-testing-solutions) — Source: Charles River
- 2026-06-25 13:46 EST — [Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow](https://biopharmsignal.com/news/CRL/charles-river-accelerates-digital-pathology-with-ai-powered-end-to-end-workflow) — Source: Charles River
- 2026-06-25 13:46 EST — [Charles River Laboratories Announces First-Quarter 2026 Results](https://biopharmsignal.com/news/CRL/charles-river-laboratories-announces-first-quarter-2026-results) — Source: Charles River
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)